Kyn Therapeutics Strengthens Leadership Team with Key Appointments
BOSTON--(BUSINESS WIRE)--May 7, 2019--Kyn Therapeutics, a clinical-stage biotechnology company developing highly differentiated cancer immunotherapies, today announced the appointm…
BOSTON--(BUSINESS WIRE)--May 7, 2019--Kyn Therapeutics, a clinical-stage biotechnology company developing highly differentiated cancer immunotherapies, today announced the appointm…